FDA sets decision date for Alvotech's Humira biosimilar
BioPharma
Stay updated with breaking news from Mark Levick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alvotech Announces Changes to its Leadership Team - read this article along with other careers information, tips and advice on BioSpace
Hafrun Fridriksdottir, previously Executive VP and Head of Global R&D at Teva, will become Chief Operating Officer Mark Levick has decided to step down...
Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide announced today that the Therapeutic Goods Administration of... | November 14, 2022
REYKJAVIK, Iceland, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture...